IO Biotech Inc. (IOBT)
NASDAQ: IOBT
· Real-Time Price · USD
1.44
-0.07 (-4.64%)
At close: Jun 04, 2025, 3:59 PM
1.54
6.85%
After-hours: Jun 04, 2025, 07:59 PM EDT
-4.64% (1D)
| Bid | 1.42 |
| Market Cap | 94.87M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -98.45M |
| EPS (ttm) | -1.48 |
| PE Ratio (ttm) | -0.97 |
| Forward PE | -1.49 |
| Analyst | Buy |
| Ask | 1.54 |
| Volume | 187,900 |
| Avg. Volume (20D) | 173,600 |
| Open | 1.43 |
| Previous Close | 1.51 |
| Day's Range | 1.41 - 1.66 |
| 52-Week Range | 0.66 - 1.73 |
| Beta | 0.37 |
About IOBT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IOBT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IOBT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts8 months ago
+3.22%
IO Biotech share are trading higher after announce...
Unlock content with
Pro Subscription
9 months ago
IO Biotech shares are trading lower after the company announced the IDMC observed no new safety signals in the Phase 3 trial of IO102-IO103. Also, Morgan Stanley maintained an Overweight rating on the stock but lowered its price target from $7 to $4.
